Activated charcoal forms non-IgE binding complexes with peanut proteins

Journal of Allergy and Clinical Immunology

Volumn 112, Issue 1, 2003, Pages 175-179

  Vadas, Peter ^a   Perelman, Boris ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Activated; Allergy; Anaphylaxis; Ara h1; Ara h2; Charcoal; Complex; ELISA; IgE; Peanut

Indexed keywords

ACTIVATED CARBON; CHARCOAL; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; PEANUT PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ABSORPTION; ARTICLE; CACAO; CENTRIFUGATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GASTROINTESTINAL TRACT; HUMAN; ICE CREAM; INCUBATION TIME; INGESTION; PEANUT; PEANUT ALLERGY; PRIORITY JOURNAL; PROTEIN BINDING; SKIN TINGLING; WESTERN BLOTTING;

EID: 0037666878     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2003.1480     Document Type: Article

References (18)

1. Krenzelok EP, Leikin JB. Approach to the poisoned patient. Dis Mon 1996;42:509-607.
2. Nelson HS, Lahr J, Rule R, Bock A, Leung D. Treatment of anaphylactic sensitivity to peanuts by immunotherapy with injections of aqueous peanut extract. J Allergy Clin Immunol 1997;99:44-51.
3. Bowden CA, Krenzelok EP. Clinical applications of commonly used contemporary antidotes: a US perspective. Drug Saf 1997;16:9-47.
4. Manoguerra AS. Gastrointestinal decontamination after poisoning: where is the science? Crit Care Clin 1997;13:709-25.
5. American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists Study Group. Position statement and practice guidelines on the use of multi-dose activated charcoal in the treatment of acute poisoning. J Toxicol Clin Toxicol 1999;37:731-51.
6. Lapatto-Reiniluoto O, Kivisto KT, Neuvonen PJ. Effect of activated charcoal alone or given after gastric lavage in reducing the absorption of diazepam, ibuprofen and citalopram. Br J Clin Pharmacol 1999;48:148-53.
7. Laine K, Kivisto KT, Pelttari S, Neuvonen PJ. The effect of activated charcoal on the absorption of fluoxetine, with special reference to delayed charcoal administration. Pharmacol Toxicol 1996;79:270-3.
8. Gittelman MA, Stephan M, Perry H. Acute pediatric digoxin ingestion. Pediatr Emerg Care 1999;15:359-62.
9. Rance F, Dutau G. Peanut hypersensitivity in children. Pediatr Pulmonol Suppl 1999;18:165-7.
10. Clarke McKilburn SA, Hourihane JO, Dean KR, Warner JO, Dean TP. Serological characteristics of peanut allergy. Clin Exp Allergy 1998;28:1251-7.
11. Hourihane JO. Peanut allergy: current status and future challenges. J Clin Exp Allergy 1997;27:1240-6.
12. Sicherer SH, Munoz-Furlong A, Burks AW, Sampson HA. Prevalence of peanut and tree nut allergy in the US determined by a random dial telephone survey. J Allergy Clin Immunol 1999;103:559-62.
13. Nordlee JA, Taylor SL, Jones RT, Yuninger JW. Allergenicity of various peanut products as determined by RAST inhibition. J Allergy Clin Immunol 1981;68:376-82.
14. Bradford MM. A refined and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
15. Laemmli UK. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
16. Hourihane JO, Kilburn SA, Nordlee JA, Hefle SL, Taylor SL, Warner JO. An evaluation of the sensitivity of subjects with peanut allergy to very low doses of peanut protein: a randomized, double-blind, placebo-controlled food challenge study. J Allergy Clin Immunol 1997;100:596-600.
17. Crockett R, Krishel SJ, Manoguerra A, Williams SR, Clark RF. Prehospital use of activated charcoal: a pilot study. J Emerg Med 1996;14:335-8.
18. Allison TB, Gough JE, Brown LH, Thomas SH. Potential time savings by prehospital administration of activated charcoal. Prehosp Emerg Care 1997;1:73-5.